Akso Health Group
AHG
$1.35
$0.00290.22%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 14.83% | 14.83% | -92.46% | -92.46% | -78.28% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.83% | 14.83% | -92.46% | -92.46% | -78.16% |
| Cost of Revenue | 21.67% | 21.67% | -92.03% | -92.03% | -- |
| Gross Profit | -41.76% | -41.76% | -96.55% | -96.55% | -- |
| SG&A Expenses | -54.86% | -54.86% | 74.93% | 74.93% | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -48.98% | -48.98% | -73.43% | -73.43% | 15.32% |
| Operating Income | 54.99% | 54.99% | -951.68% | -951.68% | -93.38% |
| Income Before Tax | 58.89% | 58.89% | -283.20% | -283.20% | -- |
| Income Tax Expenses | -96.55% | -96.55% | 110.17% | 110.17% | -- |
| Earnings from Continuing Operations | 58.91% | 58.91% | -286.03% | -286.03% | -- |
| Earnings from Discontinued Operations | -100.05% | -100.05% | 52.05% | 52.05% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 160.58% | 160.58% | 96.25% | 96.25% | -- |
| Net Income | -176.53% | -176.53% | -526.65% | -526.65% | 72.65% |
| EBIT | 54.99% | 54.99% | -951.68% | -951.68% | -93.38% |
| EBITDA | -- | -- | -- | -- | -93.50% |
| EPS Basic | 11.58% | 11.58% | -527.12% | -527.12% | 72.64% |
| Normalized Basic EPS | 87.16% | 87.16% | -286.10% | -286.10% | -- |
| EPS Diluted | 14.41% | 14.41% | -604.00% | -604.00% | 67.63% |
| Normalized Diluted EPS | 87.16% | 87.16% | -286.10% | -286.10% | -- |
| Average Basic Shares Outstanding | 212.60% | 212.60% | 0.00% | 0.00% | 15.07% |
| Average Diluted Shares Outstanding | 212.60% | 212.60% | 0.00% | 0.00% | 15.08% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
